Chang Liu

机构：Sinocelltech Group (China), Shenyang Ninth People's Hospital · ORCID：0000-0002-5930-3255

发表论文 78 篇 · 总被引 1467 次 · h-index 20

代表论文

• Efficacy and safety of mesenchymal stromal cell transplantation in the treatment of autoimmune and rheumatic immune diseases: a systematic review and meta-analysis of randomized controlled trials (2025 · Stem Cell Research & Therapy · 被引 32)
• Evaluating a new obesity indicator for stroke risk prediction: comparative cohort analysis in rural settings of two nations (2024 · BMC Public Health · 被引 28)
• CDKN2A was a cuproptosis-related gene in regulating chemotherapy resistance by the MAGE-A family in breast cancer: based on artificial intelligence (AI)-constructed pan-cancer risk model (2023 · Aging · 被引 15)
• Injectable HAMA-CPC hydrogels loaded with high-yield 3D bioprinted adipose-derived stem cell small extracellular vesicles for increased bone repair (2025 · Journal of Nanobiotechnology · 被引 11)
• Dual-Tracer 18F-FDG and 68Ga-PSMA PET/CT Imaging of Heterogeneous Phenotypes of Metastatic Castration-Resistant Prostate Cancer for Predicting Response to Novel Hormone Therapy (2024 · Clinical Nuclear Medicine · 被引 11)
• Evaluation of viscosity in inflammation and ferroptosis process based on a bithiophene-containing hemicyanine dye with diminished solvatochromic effect (2023 · Dyes and Pigments · 被引 8)